Ads
related to: acetylcholine release in stomach and bladder cancer patients- Treatment Efficacy Info
See How This Rx Option Is Thought
to Work and View Trial Results.
- Dosing Information
Learn About Prescription Dosing and
View the Treatment Schedule.
- Patient Resources
Download Available Resources and
View Advocacy Group Information.
- Important Safety Info
Important Safety Information for
A Bladder Cancer Rx Option.
- Treatment Efficacy Info
Search results
Results from the WOW.Com Content Network
British physiologist Sir Henry Hallett Dale (1875-1968) observed acetylcholine for causing blood vessel dilation and slowing down heart rate. In 1914, Dale noted that the physiological effect of acetylcholine resembled the stimulation of parasympathetic nervous system and hypothesized acetylcholine as the neurotransmitter.
Pyridostigmine is a medication used to treat myasthenia gravis [1] and underactive bladder. [2] It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type. [3] It is also used off-label to treat some forms of Postural orthostatic tachycardia syndrome.
A cholinergic crisis is an over-stimulation at a neuromuscular junction due to an excess of acetylcholine, [1] as a result of the inactivity of the acetylcholinesterase enzyme, which normally breaks down acetylcholine.
[1] [4] Chemicals in this family can act either directly by stimulating the nicotinic or muscarinic receptors (thus mimicking acetylcholine), or indirectly by inhibiting cholinesterase, promoting acetylcholine release, or other mechanisms. [5] Common uses of parasympathomimetics include glaucoma, Sjögren syndrome and underactive bladder. [6]
1) In the body of the stomach, the vagal postganglionic muscarinic nerves release acetylcholine (ACh) which stimulates parietal cell H+ secretion. 2) In the lamina propria of the body of the stomach the ACh released from the vagal endings triggers histamine secretion from ECL cells. Histamine also stimulates H+ secretion from parietal cells.
The muscarinic M 3 receptor regulates insulin secretion from the pancreas [7] and are an important target for understanding the mechanisms of type 2 diabetes mellitus.. Some antipsychotic drugs that are prescribed to treat schizophrenia and bipolar disorder (such as olanzapine and clozapine) have a high risk of diabetes side-effects.
The muscarinic acetylcholine receptor M 1, also known as the cholinergic receptor, muscarinic 1, is a muscarinic receptor that in humans is encoded by the CHRM1 gene. [5] It is localized to 11q13. [5] This receptor is found mediating slow EPSP at the ganglion in the postganglionic nerve, [6] is common in exocrine glands and in the CNS. [7] [8]
The muscarinic acetylcholine receptor M 2, also known as the cholinergic receptor, muscarinic 2, is a muscarinic acetylcholine receptor that in humans is encoded by the CHRM2 gene. [5] Multiple alternatively spliced transcript variants have been described for this gene. [5] It is G i-coupled, reducing intracellular levels of cAMP.
Ads
related to: acetylcholine release in stomach and bladder cancer patients